Skip to content

is There an Effect of Adding Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever

is There an Effect of Addition of Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07130305
Enrollment
40
Registered
2025-08-19
Start date
2025-05-08
Completion date
2026-01-15
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Familial Mediterranean Fever

Brief summary

Familial mediterranean fever (FMF) is common in mediterranean region. this disorder is connected with deterioration in functional performance, fitness of cardiorespiration, muscle strength, and bone mass

Detailed description

Familial mediterranean fever (FMF adolescent girls ) will be collected to be cateogarized to vibration group (vibration group) or control grouping. every group OF FMF will contain 20 FMF adolescent girls. both groups will receive vitamin D and their traditional colchicine doses daily for six months. vibration group will receive three sessions of 20-min whole body vibration in the week for 6 months

Interventions

OTHERwhole body vibration plus usual care

Familial mediterranean fever (20 FMF adolescent girls ) will be in this vibration group who will receive vitamin D and their traditional colchicine doses daily for six months. vibration group will also receive three sessions of 20-min whole body vibration in the week for 6 months

OTHERusual care

Familial mediterranean fever (20 FMF adolescent girls ) will be in this control group who will receive vitamin D and their traditional colchicine doses daily for six months.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
13 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

FMF adolecent girls ages 13 -17 years forty patients

Exclusion criteria

cardiac problems renal problems liver problems diabetes brain problems

Design outcomes

Primary

MeasureTime frameDescription
bone mineral densityit will be measured after 6 monthsit is a measure for bone density at 2-4 lumbar vertebrae

Secondary

MeasureTime frameDescription
vitamin Dit will be measured after 6 monthsit will measured in plasma as serum 25-hydroxyvitamin D
osteoprotegerinit will be measured after 6 monthsit will measured in plasma
quadriceps torqueit will be measured after 6 monthsit will measured in dominant side
z scoreit will be measured after 6 monthsit is a score for measure for bone mass at 2-4 lumbar vertebrae
Thirty second sit to stand testit will be measured after 6 monthsit is an indicator for functional performance
Ruffier indexit will be measured after 6 monthsit is an indicator for cardiorespirtory fittness
Standing long jump testit will be measured after 6 monthsit is an indicator for functional performance

Countries

Egypt

Contacts

Primary ContactAli MA Ismail, lecturer
ali.mohamed@pt.cu.edu.eg01005154209
Backup ContactAli Ismail
allooka2012@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026